14 results
424B3
PBM
Psyence Biomedical Ltd. Warrant
30 Aug 24
Prospectus supplement
4:00pm
review or approval will not be shortened.
We may seek fast track, breakthrough therapy, and/or regenerative medicine advanced therapy designations
F-1
PBM
Psyence Biomedical Ltd. Warrant
19 Aug 24
Registration statement (foreign)
4:07pm
, and/or regenerative medicine advanced therapy designations or priority review for one or more of our product candidates.
The FDA may issue a fast
424B3
PBM
Psyence Biomedical Ltd. Warrant
19 Aug 24
Prospectus supplement
9:27am
period for FDA review or approval will not be shortened.
We may seek fast track, breakthrough therapy, and/or regenerative medicine advanced therapy
POS AM
PBM
Psyence Biomedical Ltd. Warrant
12 Aug 24
Prospectus update (post-effective amendment)
5:23pm
that the time period for FDA review or approval will not be shortened.
We may seek fast track, breakthrough therapy, and/or regenerative medicine
F-1/A
jruy2 dblq8s
6 May 24
Registration statement (foreign) (amended)
8:27pm
F-1/A
bp3oui ple3u
18 Apr 24
Registration statement (foreign) (amended)
6:03am
F-1
5mg18k
9 Feb 24
Registration statement (foreign)
4:09pm
424B3
a4i0j
15 Nov 23
Prospectus supplement
4:28pm
F-4/A
7vzia
13 Nov 23
Registration of securities (foreign) (amended)
3:59pm
F-4/A
gdfyclc5nn k1n
13 Nov 23
Registration of securities (foreign) (amended)
9:27am
F-4/A
h4fzl344b3qafnq
3 Nov 23
Registration of securities (foreign) (amended)
6:17pm
F-4/A
z277zjkbw66j s2
16 Oct 23
Registration of securities (foreign) (amended)
5:29pm
F-4/A
luij23 mtzi
20 Sep 23
Registration of securities (foreign) (amended)
5:26pm
- Prev
- 1
- Next